Cargando…
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735069/ https://www.ncbi.nlm.nih.gov/pubmed/26657197 http://dx.doi.org/10.1038/bcj.2015.102 |
| _version_ | 1782413010623528960 |
|---|---|
| author | Patel, S Guerenne, L Gorombei, P Omidvar, N Schlageter, M-H Alex, A A Ganesan, S West, R Adès, L Mathews, V Krief, P Pla, M Fenaux, P Chomienne, C Padua, R A |
| author_facet | Patel, S Guerenne, L Gorombei, P Omidvar, N Schlageter, M-H Alex, A A Ganesan, S West, R Adès, L Mathews, V Krief, P Pla, M Fenaux, P Chomienne, C Padua, R A |
| author_sort | Patel, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4735069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47350692016-02-17 pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice Patel, S Guerenne, L Gorombei, P Omidvar, N Schlageter, M-H Alex, A A Ganesan, S West, R Adès, L Mathews, V Krief, P Pla, M Fenaux, P Chomienne, C Padua, R A Blood Cancer J Letter to the Editor Nature Publishing Group 2015-12 2015-12-11 /pmc/articles/PMC4735069/ /pubmed/26657197 http://dx.doi.org/10.1038/bcj.2015.102 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Patel, S Guerenne, L Gorombei, P Omidvar, N Schlageter, M-H Alex, A A Ganesan, S West, R Adès, L Mathews, V Krief, P Pla, M Fenaux, P Chomienne, C Padua, R A pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title | pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title_full | pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title_fullStr | pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title_full_unstemmed | pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title_short | pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| title_sort | pvax14dna-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735069/ https://www.ncbi.nlm.nih.gov/pubmed/26657197 http://dx.doi.org/10.1038/bcj.2015.102 |
| work_keys_str_mv | AT patels pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT guerennel pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT gorombeip pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT omidvarn pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT schlagetermh pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT alexaa pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT ganesans pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT westr pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT adesl pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT mathewsv pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT kriefp pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT plam pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT fenauxp pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT chomiennec pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice AT paduara pvax14dnamediatedaddonimmunotherapycombinedwitharsenictrioxideandalltransretinoicacidtargetedtherapyeffectivelyincreasesthesurvivalofacutepromyelocyticleukemiamice |